Related Experiment Video
Updated: May 22, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Zygomycosis in two hematologic cases
M T García-Romero1, J García-Méndez, R Arenas
1Departments of Dermatology, Hospital General Dr. Manuel Gea González, 14080 Mexico City, Mexico.
Abstract:
Zygomycosis are invasive mould infections, rarely diagnosed in hematologic patients. Most of the cases published are in patients with prolonged neutropenia, along with other risk factors such as the use of prior broad-spectrum antibiotics (including new antifungal agents, such as voriconazole), diabetes mellitus (with or without ketoacidosis), malnutrition, iron overload (with or without the use of deferoxamine). These infections have poor prognosis due to the involvement of vital anatomic structures and late diagnosis. Until recent years, the treatment was based on high doses of amphotericin B plus surgical debridement. Here we present two patients with hematologic diseases (one with leukemia, the second with aplastic anemia) with an impaired immune system and the diagnosis of zygomycosis. The survival of one of them was mainly due to early diagnosis and surgical debridement; unfortunately the second was misdiagnosed as an extensive ecchymosis due to thrombocytopenia and died with CNS involvement.
Insights
Zygomycosis is a rare but serious fungal infection in hematologic patients. Early diagnosis and surgical intervention are crucial for survival, as demonstrated in two case studies.
Area of Science:
- Mycology
- Hematology
- Infectious Diseases
Background:
- Zygomycosis, an invasive mold infection, is infrequently diagnosed in hematologic patients.
- Risk factors include prolonged neutropenia, broad-spectrum antibiotic use (e.g., voriconazole), diabetes mellitus, malnutrition, and iron overload (potentially with deferoxamine).
Observation:
- Two hematologic patients (leukemia, aplastic anemia) with impaired immunity developed zygomycosis.
- One patient survived due to prompt diagnosis and surgical debridement.
- The second patient, misdiagnosed with thrombocytopenic ecchymosis, succumbed to central nervous system involvement.
Findings:
- Zygomycosis presents a poor prognosis due to vital structure involvement and delayed diagnosis.
- Aggressive treatment historically involved amphotericin B and surgical debridement.
Implications:
- Highlights the critical need for early zygomycosis diagnosis in immunocompromised hematologic patients.
- Emphasizes the life-saving role of timely surgical intervention alongside appropriate antifungal therapy.
- Underscores the potential for fatal outcomes with misdiagnosis, particularly CNS zygomycosis.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Fungal Group Zygomycota
Graves Disease II: Pathophysiology
Cytomegalovirus Disease
Hematopoiesis
